CASIE BEER: Open Payments
NPI 1760950158 · GREENWOOD, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$437 in 25 payments from 10 companies in 2025. Trend: 2023 $532 · 2024 $447 · 2025 $437
Food & beverage: $437
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 8 | $138 |
| Astellas Pharma US Inc | 6 | $106 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $58 |
| Dexcom, Inc. | 1 | $24 |
| Hologic Sales and Service, LLC | 1 | $22 |
| CooperSurgical, Inc. | 1 | $21 |
| Organon LLC | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
| Exact Sciences Corporation | 1 | $14 |
Products named: ZURZUVAE, Veozah, Mirena, Dexcom G6 Transmitter, NOVASURE, Paragard T 380A, NEXPLANON, Auvelity.
Industry payments across IN — which companies pay providers there.
